Treating great and small saphenous vein insufficiency with histoacryl in patients with symptomatic varicose veins and increased risk of surgery

Vasa. 2018 Aug;47(5):416-424. doi: 10.1024/0301-1526/a000716. Epub 2018 Jun 12.

Abstract

Background: Treating great and small saphenous vein trunk insufficiency with cyanoacrylate glue is the least taxing treatment method of all available techniques. Due to long-term unavailability of commercial kits with n-butyl-2-cyanoacrylate (histoacryl) in the Czech Republic, we used a modified technique.

Patients and methods: Fifty-six limbs in 49 patients suffering from great saphenous vein or small saphenous vein insufficiency in combination with symptomatic chronic venous insufficiency and complicating comorbidities were treated with a modified endovascular cyanoacrylate glue application technique.

Results: The immediate success rate of the treatment was 98 %. In follow-up intervals of six weeks, six months, one year, and two years, the anatomical success rates of embolization (recanalization of no more than 5 cm of the junction) were 98, 96, 94, and 94 %, respectively. At identical intervals the venous insufficiency was scored according to the Aberdeen Varicose Vein Questionnaire and the American Venous Clinical Severity Score. In both cases, improvement was demonstrated over the two-year follow-up, with a 0.5 % significance level. Specific clinical signs of venous insufficiency were also evaluated, such as pain, oedema, clearance of varicose veins, and healing of venous ulceration. One severe complication - a pulmonary embolism - was reported, without consequences.

Conclusions: We demonstrated that treating insufficient saphenous veins with modified histoacryl application brought a relief from symptoms of venous insufficiency and that the efficiency of this technique is comparable to commonly used methods.

Keywords: Varicose veins; endovascular technique; histoacryl; lipiodol; saphenous veins; venous ulcer.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Czech Republic
  • Embolization, Therapeutic* / adverse effects
  • Enbucrilate / administration & dosage*
  • Enbucrilate / adverse effects
  • Endovascular Procedures* / adverse effects
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Prospective Studies
  • Risk Factors
  • Saphenous Vein* / diagnostic imaging
  • Saphenous Vein* / surgery
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome
  • Varicose Veins / diagnostic imaging
  • Varicose Veins / surgery
  • Varicose Veins / therapy*
  • Venous Insufficiency / diagnostic imaging
  • Venous Insufficiency / surgery
  • Venous Insufficiency / therapy*

Substances

  • Enbucrilate